@article{36da25d9b43f4131bd1d5c1223f82ee3,
title = "Overall survival after PARP maintenance treatment in platinum-sensitive relapsed ovarian cancer: opposing views of the US Food and Drug Administration and European Medicines Agency",
keywords = "Ovarian Cancer, Ovarian Neoplasms/drug therapy, United States/epidemiology, Poly(ADP-ribose) Polymerase Inhibitors/therapeutic use, Neoplasm Recurrence, Local/drug therapy, Humans, Carcinoma, Ovarian Epithelial/drug therapy, Female, United States Food and Drug Administration",
author = "Monk, {Bradley J} and Coleman, {Robert L} and Mirza, {Mansoor Raza}",
year = "2023",
month = jun,
day = "5",
doi = "10.1136/ijgc-2023-004478",
language = "English",
volume = "33",
pages = "1008--1009",
journal = "International journal of gynecological cancer : official journal of the International Gynecological Cancer Society",
issn = "1048-891X",
publisher = "Lippincott Williams & Wilkins",
number = "6",
}